E. Peterson

发表

Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

R. Holman, F. Van de Werf, Zhen Huang, 2017, Diabetes Care.

Trends of blood pressure control in the U.S. during the COVID-19 pandemic

B. Shah, K. Chiswell, A. Navar, 2021, American Heart Journal.

Association Between Patient Survival and Clinician Variability in Treatment Rates for Aortic Valve Stenosis

M. Leon, V. Thourani, Tracy Y. Wang, 2021, Journal of the American Heart Association.

Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials

Manesh R. Patel, Sunil V. Rao, R. Califf, 2021, JAMA network open.

Outcomes of a multi‐community hypertension implementation study: the American Heart Association's Check. Change. Control. program

Emily C. O'Brien, Monique L. Anderson, E. O'Brien, 2017, Journal of clinical hypertension.

Pancreatic Safety of Sitagliptin in the TECOS Trial

R. Holman, S. Stevens, J. Lachin, 2017 .

Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison.

Neha J. Pagidipati, C. Granger, D. McGuire, 2022, Journal of the American College of Cardiology.

Lipoprotein(a) Testing Patterns in a Large Health System.

S. Rhodes, S. Kent, E. Peterson, 2021, The American journal of cardiology.

Validation of the WATCH‐DM and TRS‐HFDM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis

R. Holman, M. Vaduganathan, A. Pandey, 2022, Journal of the American Heart Association.

Trajectories of Non-HDL C Across Midlife: Implications for Cardiovascular Prevention

M. Pencina, J. Wilkins, K. Pencina, 2020 .

Statin Recommendations for Primary Prevention: More of the Same or Time for a Change?

A. Navar, E. Peterson, 2022, JAMA.

Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease

R. Holman, A. Pandey, S. Stevens, 2022, Cardiovascular Diabetology.

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial

R. Holman, P. Armstrong, H. Rodbard, 2017, Diabetes, obesity & metabolism.

The Usage Patterns of Cardiac Bedside Markers Employing Point‐of‐Care Testing for Troponin in Non‐ST‐Segment Elevation Acute Coronary Syndrome: Results from CRUSADE

W. Gibler, E. Ohman, E. Peterson, 2009, Clinical cardiology.

Should Cardiovascular Preventive Therapy Be Over-the-Counter?

N. Pagidipati, E. Peterson, 2021, Journal of the American College of Cardiology.

Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype

R. Holman, P. Armstrong, F. Van de Werf, 2018, Diabetes Care.

Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice.

A. Navar, E. Peterson, M. Nanna, 2022, JAMA cardiology.

Using EHR data to identify coronavirus infections in hospitalized patients: Impact of case definitions on disease surveillance

A. Navar, R. Sobel, E. Peterson, 2022, International Journal of Medical Informatics.

Normal coronary rates for elective angiography in the Veterans Affairs Healthcare System: insights from the VA CART program (veterans affairs clinical assessment reporting and tracking).

G. Grunwald, J. Rumsfeld, P. Ho, 2014, Journal of the American College of Cardiology.

Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.

D. Singer, B. Gersh, P. Kowey, 2015, American heart journal.

Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020

Justin F. Rousseau, G. Flaker, A. Navar, 2022, Journal of the American Heart Association.

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.

V. Hasselblad, R. Califf, J. Piccini, 2009, Journal of the American College of Cardiology.

Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2‐VASc Scores: Findings From the ORBIT‐AF I and II Registries

D. Singer, B. Gersh, P. Kowey, 2018, Journal of the American Heart Association.

Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes.

Emily C. O'Brien, Neha J. Pagidipati, P. Joshi, 2023, American journal of preventive cardiology.

Check It, Change It: A Community-Based Intervention to Improve Blood Pressure Control

Kevin L. Thomas, R. Califf, B. Shah, 2013, Circulation. Cardiovascular quality and outcomes.

Challenges to Bp Control

Kevin L. Thomas, R. Califf, B. Shah, 2022 .

Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry.

J. D. de Lemos, Tracy Y. Wang, E. Peterson, 2016, American heart journal.

The Association Between Low‐Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts

A. Navar, E. Peterson, D. Wojdyla, 2019, Journal of the American Geriatrics Society.

Evaluating the Impact of Public Health Notification

R. Califf, K. Anstrom, P. Douglas, 2012 .

The importance of weight stabilization amongst those with overweight or obesity: Results from a large health care system

Neha J. Pagidipati, Ricardo Henao, N. Pagidipati, 2021, Preventive medicine reports.

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.

R. Holman, P. Armstrong, S. Goodman, 2018, Diabetes care.

Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry.

R. Califf, R. Lopes, E. Mesquita, 2014, American heart journal.

The impact of race and ethnicity on outcomes in 19,584 adults hospitalized with COVID-19

A. Navar, E. Peterson, Q. Hou, 2021, PloS one.

Antiarrhythmic Drug Use in Patients <65 Years of Age With Atrial Fibrillation and Without Structural Heart Disease

P. Piccini, N. LaPointe, S. Al‐Khatib, 2015 .

Does Early Detection of Atrial Fibrillation Reduce the Risk of Thromboembolic Events? Rationale and Design of the Heartline Study.

R. Passman, J. Ruskin, M. Turakhia, 2023, American heart journal.

Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice.

A. Navar, Nishant P. Shah, E. Peterson, 2023, Journal of clinical lipidology.

Facilitating Shared Decision Making Among Black Patients at Risk for Sudden Cardiac Arrest

Kevin L. Thomas, David S. Hirsh, A. Kosinski, 2023, Annals of Internal Medicine.

Age and Persistent Use of Cardiovascular Medication After Acute Coronary Syndrome: Results from Medication Applied and Sustained Over Time

Chiara Melloni, Fang-Shu Ou, K. Alexander, 2009, Journal of the American Geriatrics Society.

Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated?

R. Califf, L. Shaw, L. Newby, 1996, American heart journal.

The Cumulative Impact of Chronic Stressors on Risks of Myocardial Infarction in US Older Adults

L. George, Matthew E. Dupre, A. Navar, 2021, Psychosomatic medicine.

Modeling the Association of Volume vs Composite Outcome Thresholds With Outcomes and Access to Transcatheter Aortic Valve Implantation in the US.

Sean M. O'Brien, J. Carroll, N. Desai, 2023, JAMA cardiology.

The Texas Health Resources Clinical Scholars Program: Learning healthcare system workforce development through embedded translational research

Ferdinand T. Velasco, A. Pandey, A. Masica, 2022, Learning Health Systems.

Cardiology management improves secondary prevention measures among patients with coronary artery disease.

G. Grunwald, J. Rumsfeld, K. Hammermeister, 2004, Journal of the American College of Cardiology.

The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.

Robert M Califf, R. Califf, M. Mack, 2005, American heart journal.

The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Ini

W. Gibler, E. Ohman, Sidney C. Smith, 2006, American heart journal.

Obesity and age of first non-ST-segment elevation myocardial infarction.

W. Gibler, E. Ohman, B. Franklin, 2008, Journal of the American College of Cardiology.

Significant variation in P2Y12 inhibitor use after peripheral vascular intervention in Medicare beneficiaries.

Laura G. Qualls, E. Peterson, Manesh R Patel, 2016, American heart journal.

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

Jennifer G. Robinson, V. Roger, E. Peterson, 2018, Journal of the American Heart Association.

The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes.

R. Califf, E. Braunwald, L. Newby, 2006, American heart journal.

Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry

Jennifer G. Robinson, V. Roger, E. Peterson, 2018, JAMA cardiology.

Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSAD

W. Gibler, E. Ohman, Sidney C. Smith, 2006, American heart journal.

Pancreatic Safety of Sitagliptin in the TECOS Study

R. Holman, E. Peterson, S. Stevens, 2016, Diabetes Care.

Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.

J. Rumsfeld, E. Peterson, W. Borden, 2014, Journal of the American College of Cardiology.

Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction.

L. Newby, W. Gibler, E. Ohman, 2007, American heart journal.

Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE).

W. Gibler, E. Ohman, Sidney C. Smith, 2005, The American journal of cardiology.

Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.

W. Borden, T. Maddox, F. Masoudi, 2014, Journal of the American College of Cardiology.

Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada.

R. Califf, D. Mark, P. Armstrong, 2003, American heart journal.

TROPONIN ELEVATION AS A MANIFESTATION OF COVID-19 MYOCARDIAL INFLAMMATION ASSOCIATED WITH INCREASED MORTALITY

C. Granger, D. McGuire, N. Pagidipati, 2022, Journal of the American College of Cardiology.

Patient perceptions and use of non‐statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry

Jennifer G. Robinson, V. Roger, A. Goldberg, 2021, Clinical cardiology.

Generalizability of an EHR-Network Dataset to the United States for Cardiovascular Disease Conditions: Comparison of Cerner Real World Data with the National Inpatient Sample.

A. Navar, E. Peterson, C. Page, 2023, American heart journal.

Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes.

K. Alexander, L. Newby, W. Gibler, 2008, American heart journal.

Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in women.

V. Hasselblad, L. Newby, E. Ohman, 2002, American heart journal.